What the Health?

Wellness news and notes

Archive for December 6th, 2012

Asthma rising in Connecticut

by:

Asthma rates in the state are rising, and residents of the state’s five largest cities are more likely to hospitalized with the condition than anywhere else in the state.

That’s according to the Connecticut Department of Public Health report “The Burden of Asthma in Connecticut — 2012 Surveillance Report,” , released today. The report offers a comprehensive look at asthma in the state up to 2010, using information from a variety of sources, including the Centers for Disease Control and Prevention’s 2010 Behavioral Risk Factor Surveillance System.

The Connecticut report is done every three years. This year’s report show, among other things, that the prevalence of Connecticut adults with asthma in by 17.9 percent between 2000 and 2010, and rose 7.6 percent among children between 2005 and 2010. Since 2000, asthma prevalence in the state has been higher than national prevalence rates. That’s actually true of all the New England states, said Eileen Boulay, registered nurse and asthma program manager for Connecticut DPH. The reasons for this are unknown, Boulay said.

“We have different climate conditions here,” she said. “We have older housing. We have a lot of highways going through. “It’s hard to know, because we don’t exactly know what causes asthma.”

Asthma is a chronic respiratory disease that affects millions of Americans. There is no cure, but sysmptoms can be controlled through medication and other interventions.

As of 2010, about 89,300 children and 246,100 adults in the state had asthma. In 2009 alone, there were 5,146 hospitalizations and 24,239 emergency department visits attributed to asthma. That year, the combined asthma hospitalization rate for the five largest Connecticut cities — Bridgeport, Hartford, New Haven, Stamford and Waterbury — was the 3.4 times greater than the combined asthma hospitalization rate for the rest of the state. New Haven residents had the highest asthma hospitalization rate.

That’s not particularly shocking, Boulay said, but what did surprise researchers is that, between 2005 and 2009, the asthma emergency department visit rate for Hispanic children increased 50.9 percent. “That was a very telling number,” she said. “This is a controllable disease. If you already have things in place (to manage it), you don’t end up in the ED.”

Boulay said the point of the report is to unearth statistics like these. “We then have to look at what’s not being managed and address these issues,” she said.

A genetic resistance to smoking cessation?

by:

You’re aware of all the health risks of smoking, as well as the habit’s impact on your wallet, but you just can’t bring yourself to quit. The answer may lie in your genes.

New research from the Yale University School of Public Health suggests that individuals’ genetics play an important role in whether they respond to tobacco-control policies. The study appears online in the journal PLOS ONE.

According to the research, smoking dropped sharply after the Surgeon General’s landmark report on the dangers of tobacco was published in 1964, but rates have plateaued during the past two decades despite increasingly stringent measures to persuade people to quit. The study found biological evidence that may help explain why some people respond to anti-smoking inducements, such as higher taxes and the expansion of clean-air laws, and why others do not.

“We found that for people who are genetically predisposed to tobacco addiction, higher cigarette taxes were not enough to dissuade them from smoking,” said lead researcher Jason M. Fletcher, associate professor in the Department of Health Policy and Management at the Yale School of Public Health in a press release. Fletcher, also a former Robert Wood Johnson Foundation Health & Society Scholar, examined the interplay between state-level tobacco taxation and a nicotinic receptor gene in a cross-section of U.S. adults.

The “gene-policy interaction” study found that variations in the nicotine receptor were linked to the influence of higher taxes on multiple measures of tobacco use. Individuals with a specific genetic variant decreased their tobacco use by nearly 30 percent when facing high tobacco taxes, while individuals with an alternative genetic variant had no response.

Tobacco use remains the leading cause of preventable death in the United States, and is responsible for more than 400,000 deaths each year, according to the study. Tobacco taxation, meanwhile, has been credited with helping to reduce use by more than 50 percent since the Surgeon General’s report.

The paper can be viewed at http://dx.plos.org/10.1371/journal.pone.0050576. Funding for the study was provided by a seed grant from the Robert Wood Johnson Foundation Health & Society Scholars Program at Columbia University.

Page 1 of 11